A promising new technology for Parkinson's disease

A framework for multidisciplinary management of autonomic dysfunction in Parkinson disease.

Parkinsonism & related disorders·2026

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Movement disorders : official journal of the Movement Disorder Society·2026

Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease.

Journal of Parkinson's disease·2026

Thermoregulatory Dysfunction in Parkinson's Disease: Mechanisms, Implications, and Therapeutic Perspectives.

Cells·2025

Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease.

Parkinsonism & related disorders·2024

Movement Disorders and the Gut: A Review.

Movement disorders clinical practice·2022

Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment.

Neurology·2026

Clinical Reasoning: A 79-Year-Old Man With Subacute Onset Involuntary Facial Movements and Discoordination.

Neurology·2026

Machine Learning Characterization of Readmissions After Chronic Subdural Hematoma Hospitalizations.

Neurology·2026

Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Neurology·2026

Pearls & Oy-sters: Bilateral Neuropathic Facial Pain With Autonomic Features and Neurovascular Contact.

Neurology·2026

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Neurology·2026

Spatial control of Nd3+ sensitizer in 808 nm excited upconversion nanocrystals towards nearly 100% energy migration efficiency.

Chemical science·2026

Integrated full-color emission and near-infrared phosphorescence enabled by tunable self-assembly of a single chromophore.

Chemical science·2026

Supramolecular Nrf2-activating peptide nanotherapeutics enable deep retinal penetration and RPE targeting for dry age-related macular degeneration.

Materials today. Bio·2026

Decoding shape- and type-dependent cellular toxicity of plasmonic nanoparticles in healthy and cancer cells.

Nanotoxicology·2026

Mucosa-penetrating NIR-II nanomedicine for precision photoimmunotherapy of bladder cancer.

Biomaterials·2026

Mesembryanthemum crystallinum -guided green synthesis of ZnO nanoparticles with selective anticancer activity via ROS-mediated mitochondrial dysfunction.

Bioresources and bioprocessing·2026

Related Experiment Videos

A promising new technology for Parkinson's disease

Related Concept Videos

A framework for multidisciplinary management of autonomic dysfunction in Parkinson disease.

Longitudinal Dynamics of Polyglutamine-Expanded ATXN3 in Biofluids of Spinocerebellar Ataxia Type 3.

Consensus expert recommendations for management of dysphagia during hospital admission in Parkinson's disease.

Thermoregulatory Dysfunction in Parkinson's Disease: Mechanisms, Implications, and Therapeutic Perspectives.

Consensus practice recommendations for management of gastrointestinal dysfunction in Parkinson disease.

Movement Disorders and the Gut: A Review.

Comparison of Brain Age With Standard MRI Assessment for Dementia Risk Stratification in Subjective and Mild Cognitive Impairment.

Clinical Reasoning: A 79-Year-Old Man With Subacute Onset Involuntary Facial Movements and Discoordination.

Machine Learning Characterization of Readmissions After Chronic Subdural Hematoma Hospitalizations.

Acute Attack Treatment Escalation and Subsequent Relapse Risk in Pediatric Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.

Pearls & Oy-sters: Bilateral Neuropathic Facial Pain With Autonomic Features and Neurovascular Contact.

Quantifying Disease Progression in Patients With Charcot-Marie-Tooth Neuropathy Type 1A Using Quantitative Muscle MRI and Clinical Outcomes.

Spatial control of Nd3+ sensitizer in 808 nm excited upconversion nanocrystals towards nearly 100% energy migration efficiency.

Integrated full-color emission and near-infrared phosphorescence enabled by tunable self-assembly of a single chromophore.

Supramolecular Nrf2-activating peptide nanotherapeutics enable deep retinal penetration and RPE targeting for dry age-related macular degeneration.

Decoding shape- and type-dependent cellular toxicity of plasmonic nanoparticles in healthy and cancer cells.

Mucosa-penetrating NIR-II nanomedicine for precision photoimmunotherapy of bladder cancer.

Mesembryanthemum crystallinum -guided green synthesis of ZnO nanoparticles with selective anticancer activity via ROS-mediated mitochondrial dysfunction.

Related Experiment Videos

A promising new technology for Parkinson's disease

Related Concept Videos

Related Articles